Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk ('ugly') locally advanced rectal cancer: study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT)

Autor: van den Berg, K., Schaap, D. P., Voogt, E. L. K., Buffart, T. E., Verheul, H. M. W., de Groot, J. W. B., Verhoef, C., Melenhorst, J., Roodhart, J. M. L., de Wilt, J. H. W., van Westreenen, H. L., Aalbers, A. G. J., van 't Veer, M., Marijnen, C. A. M., Vincent, J., Simkens, L. H. J., Peters, N. A. J. B., Berbée, M., Werter, I. M., Snaebjornsson, P., Peulen, H. M. U., van Lijnschoten, I. G., Roef, M. J., Nieuwenhuijzen, G. A. P., Bloemen, J. G., Willems, J. M. W. E., Creemers, G. J. M., Nederend, J., Rutten, H. J. T., Burger, J. W. A.

Publikováno v: BMC Cancer, 22(1):957. BioMed Central Ltd
BMC Cancer, 22(1):957. BioMed Central
BMC Cancer, 22
BMC Cancer, 22(1):957. BioMed Central Ltd.
BMC Cancer, 22, 1
van den Berg, K, Schaap, D P, Voogt, E L K, Buffart, T E, Verheul, H M W, de Groot, J W B, Verhoef, C, Melenhorst, J, Roodhart, J M L, de Wilt, J H W, van Westreenen, H L, Aalbers, A G J, van 't Veer, M, Marijnen, C A M, Vincent, J, Simkens, L H J, Peters, N A J B, Berbée, M, Werter, I M, Snaebjornsson, P, Peulen, H M U, van Lijnschoten, I G, Roef, M J, Nieuwenhuijzen, G A P, Bloemen, J G, Willems, J M W E, Creemers, G J M, Nederend, J, Rutten, H J T & Burger, J W A 2022, ' Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk ("ugly") locally advanced rectal cancer : study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT) ', BMC Cancer, vol. 22, no. 1, 957, pp. 957 . https://doi.org/10.1186/s12885-022-09947-w

Background The presence of mesorectal fascia (MRF) invasion, grade 4 extramural venous invasion (EMVI), tumour deposits (TD) or extensive or bilateral extramesorectal (lateral) lymph nodes (LLN) on MRI has been suggested to identify patients with ind

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5e5e66763b1aab2bcbd20c945d69797
https://doi.org/10.1186/s12885-022-09947-w

The ORCHESTRA trial; A phase III trial of adding tumour debulking to systemic therapy versus systemic therapy alone in multi-organ metastatic colorectal cancer (mCRC)

Autor: Bakkerus, L., Gootjes, E. C., van der Stok, E. P., Buffart, T. E., Zonderhuis, B. M., Tuynman, J. B., Meijerink, M. P., van de Ven, P. M., Haasbeek, C. J., Ten Tije, A. J., de Groot, J. W., Radema, S. A., Hendriks, M. P., Helgason, H. H., van Meerten, E., Nuyttens, J. J., Grunhagen, D. J., Verhoef, C., Verheul, H. M. W.

Publikováno v: Bakkerus, L, Gootjes, E C, van der Stok, E P, Buffart, T E, Zonderhuis, B M, Tuynman, J B, Meijerink, M P, van de Ven, P M, Haasbeek, C J, Ten Tije, A J, de Groot, J W, Radema, S A, Hendriks, M P, Helgason, H H, van Meerten, E, Nuyttens, J J, Grunhagen, D J, Verhoef, C & Verheul, H M W 2019, ' The ORCHESTRA trial; A phase III trial of adding tumour debulking to systemic therapy versus systemic therapy alone in multi-organ metastatic colorectal cancer (mCRC) ', Annals of Oncology, vol. 30 .
Annals of Oncology, 30. Oxford University Press

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::760ce3ae1903af7e26280c50536ee95c
https://research.vumc.nl/en/publications/1a4d255b-627b-4811-a494-bdac5a8117a3

MAL promoter hypermethylation as a novel prognostic marker in gastric cancer.

Autor: Buffart, T. E.¹, Overmeer, R. M.¹, Steenbergen, R. D. M.¹, Tijssen, M.¹, van Grieken, N. C. T.¹, Snijders, P. J. F.¹, Grabsch, H. I.², van de Velde, C. J. H.³, Carvalho, B.¹, Meijer, G. A.¹ ga.meijer@vumc.nl

Publikováno v: British Journal of Cancer. 12/2/2008, Vol. 99 Issue 11, p1802-1807. 6p. 3 Charts, 3 Graphs.

Erratum: Deletion of chromosome 4q predicts outcome in Stage II colon cancer patients (Analytical Cellular Pathology (2010) 33: 2 (95-104))

Autor: Brosens, R. P.M., Belt, E. J.T.H., Haan, J. C., Buffart, T. E., Carvalho, B., Grabsch, H., Quirke, P., Cuesta, M. A., Engel, A. F., Ylstra, B., Meijer, G. A.

Publikováno v: Cellular Oncology, 34(3), 279-280. IOS Press
Brosens, R P M, Belt, E J T H, Haan, J C, Buffart, T E, Carvalho, B, Grabsch, H, Quirke, P, Cuesta, M A, Engel, A F, Ylstra, B & Meijer, G A 2011, ' Erratum : Deletion of chromosome 4q predicts outcome in Stage II colon cancer patients (Analytical Cellular Pathology (2010) 33: 2 (95-104)) ', Cellular Oncology, vol. 34, no. 3, pp. 279-280 . https://doi.org/10.1007/s13402-011-0055-3

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::54dec6b6648eae3a6abbe74e33b21fb4
https://research.vumc.nl/en/publications/bfe50a25-319c-4362-bf1d-6157447a2db5

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.